Ernst Ulsperger
Impact in
- Oncology top 5%
- Lung Cancer Research Studies
- Cancer Cells and Metastasis
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 27
- Lung Cancer Research Studies 14
- Cancer Treatment and Pharmacology 5
- Peptidase Inhibition and Analysis 5
- Colorectal Cancer Treatments and Studies 4
-
- Lung Cancer Treatments and Mutations 10
- Prostate Cancer Treatment and Research 3
- Co-authors
- Gerhard Hamilton (17 shared papers)Gerhard Baumgartner (7 shared papers)K Karrer (6 shared papers)Barbara H. Rath (7 shared papers)Lama Sakr (1 shared paper)Robert Zeillinger (4 shared papers)Rodryg Ramlau (4 shared papers)N. Ghilezan (4 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)Lung Cancer (4 papers)International Journal of Oncology (3 papers)Annals of Hematology (2 papers)Investigational New Drugs (2 papers)
- Partner nations
- AustriaGermanyUnited Kingdom
In The Last Decade
Ernst Ulsperger
43 papers receiving 865 citations
Peers
Comparison fields: 5 of 74
- Oncology 464
- Pulmonary and Respiratory Medicine 286
- Cancer Research 105
- Immunology and Allergy 32
- Geriatrics and Gerontology 14
Countries citing papers authored by Ernst Ulsperger
This map shows the geographic impact of Ernst Ulsperger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ernst Ulsperger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ernst Ulsperger more than expected).
Fields of papers citing papers by Ernst Ulsperger
This network shows the impact of papers produced by Ernst Ulsperger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ernst Ulsperger. The network helps show where Ernst Ulsperger may publish in the future.
Co-authors
The 25 scholars most cited alongside Ernst Ulsperger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 255 | |
| 2 | 1998 | 98 | |
| 3 | 2017 | 73 | |
| 4 | 2012 | 53 | |
| 5 | 2006 | 50 | |
| 6 | 1995 | 35 | |
| 7 | 2011 | 34 | |
| 8 | 2009 | 29 | |
| 9 | 2019 | 21 | |
| 10 | 2016 | 21 | |
| 11 | 1999 | 18 | |
| 12 | 1991 | 18 | |
| 13 | Basic clinical parameters predict gefitinib efficacy in non-small cell lung cancer. | 2011 | 16 |
| 14 | 1999 | 15 | |
| 15 | 2019 | 14 | |
| 16 | Docetaxel in the treatment of non-small cell lung cancer (NSCLC) -- an observational study focusing on symptom improvement. | 2013 | 14 |
| 17 | 2000 | 11 | |
| 18 | 2006 | 11 | |
| 19 | 1990 | 10 | |
| 20 | Osseous metastases in breast cancer: radiographic monitoring of therapeutic response. | 2002 | 9 |
About Ernst Ulsperger
Ernst Ulsperger is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Epidemiology and Pathology and Forensic Medicine, having authored 45 papers that have together received 889 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (14 papers), Neuroendocrine Tumor Research Advances (10 papers), Lung Cancer Treatments and Mutations (10 papers), Cancer Treatment and Pharmacology (5 papers), Cancer therapeutics and mechanisms (5 papers), Peptidase Inhibition and Analysis (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and Prostate Cancer Treatment and Research (3 papers). The work is most often cited by research in Oncology (464 citations), Pulmonary and Respiratory Medicine (286 citations), Cancer Research (105 citations), Immunology and Allergy (32 citations) and Geriatrics and Gerontology (14 citations). Ernst Ulsperger has collaborated with scholars based in Austria, Germany and United Kingdom. Frequent co-authors include Gerhard Hamilton, Gerhard Baumgartner, K Karrer, Barbara H. Rath, Lama Sakr, Robert Zeillinger, Rodryg Ramlau, N. Ghilezan, Valentina Tzekova and M. Wenczl. Their work appears in journals such as Journal of Clinical Oncology, Lung Cancer, International Journal of Oncology, Annals of Hematology and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.